Recombinant ITGAL (Efalizumab Biosimilar) antibody

Catalog No. ABIN7597648

Product Details anti-ITGAL (Efalizumab Biosimilar) Antibody

Target: ITGAL (Efalizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Expression System: Mammalian cells

Clonality: Chimeric

Conjugate: This ITGAL (Efalizumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Purpose: Research Grade Efalizumab Biosimilar Antibody

Specificity: CD11A, Leukocyte function-associated molecule 1 alpha chain, Leukocyte adhesion glycoprotein LFA-1 alpha chain, LFA-1A, CD11 antigen-like family member A, CD11a, ITGAL, Integrin alpha-L

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Grade: Research Grade

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for ITGAL (Efalizumab Biosimilar)

Target: ITGAL (Efalizumab Biosimilar)

Alternative Name: Efalizumab Biosimilar (ITGAL (Efalizumab Biosimilar) Products)

Target Type: Biosimilar

Background: CD11A, Leukocyte function-associated molecule 1 alpha chain, Leukocyte adhesion glycoprotein LFA-1 alpha chain, LFA-1A, CD11 antigen-like family member A, CD11a, ITGAL, Integrin alpha-L

UniProt: P20701

CAS-No: 214745-43-4